● 房颤、抗栓领域著名专家
    ● 执笔ACCP-8 抗栓指南，ESC 2010房颤管理指南“卒中预防”章节首席作者 
    Professor GYH Lip MD FRCP FACC FESC has research interests in atrial fibrillation， hypertension， heart failure， thrombosis and antithrombotic therapy， and ethnic differences in vascular disease. In addition， he has a major interest into the psychophysiology and understanding of the disease process in cardiovascular disease (including atrial fibrillation)， as well as physician and patient perceptions of antithrombotic management strategies. Finally， he leads a laboratory-based research group into thrombosis and vascular biology in cardiovascular disease and stroke.  
    Professor Lip has a national and international profile in atrial fibrillation， thrombosis and antithrombotic therapy.   
    He is editor-in-chief (Clinical Studies) for Thrombosis and Haemostasis， co-editor for the Journal of Human Hypertension， and Associate Editor for Thrombosis Research. He is currently on the Editorial Boards of Circulation， Journal of the American College of Cardiology， American Journal of Cardiology， Heart， ATVB， Blood Coagulation & Fibrinolysis， Hypertension， American Journal of Hypertension， and Blood Pressure.He has acted as referee for numerous journals， as well as major national and international grant giving bodies.
    Professor Lip was Clinical Adviser to the guideline development group that wrote the UK National Institute for Health and Clinical Excellence (NICE) evidence-based national guidelines on the management of atrial fibrillation (2006).  
    He is a coauthor of the eighth ACCP Guidelines for Antithrombotic Therapy， which are international guidelines for the use of antithrombotic therapy， and will act as deputy editor for the ninth edition of this guideline. He is section lead for ‘stroke prevention’ for the 2010 ESC Guidelines for the Management of Atrial Fibtrillation. In addition， he has also contributed to guidelines from the European Heart Rhythm Association. He is currently a Nucleus Committee Member of the European Society of Cardiology Working Group on ‘Hypertension and the Heart’， and is secretary of the Scientific Documents Committee of the European Heart Rhythm Association.     
    Professor Lip has served on many clinical trial steering committees – being involved in study design， organisation and conduct - as well as trial Data Safety Monitoring Boards. He is currently the lead for the cardiovascular research programme for Sandwell and West Birmingham NHS Hospitals NHS Trust， as well as Clinical Lead for the Birmingham and Black Country Cardiovascular Clinical Comprehensive Local Research Network. 
    Professor Lip has been involved in local epidemiological surveys of thromboprophylaxis for atrial fibrillation， and formulation of regional/national antithrombotic therapy guidelines for atrial fibrillation. He has published and lectured extensively on the clinical epidemiology of atrial fibrillation and hypertension， as well as on the pathophysiology of thrombosis in cardiovascular disease.